The femur as a presenting site is seen in 20% of cases of solitary myeloma of bone (Wiltshaw 1971) . Wiltshaw believes that solitary myeloma of bone is a rare form of presentation of myelomatosis and not a separate entity. When it becomes disseminated, as in this patient, the picture is indistinguishable from the typical disease we know as multiple myelomatosis.
In the MRC trial (Medical Research Council 1971) comparing melphalan and cyclophosphamide in myelomatosis, it was shown that the most important single factor affecting prognosis was the blood urea level at presentation. Peto (1971) has analysed data from that trial and showed that death rate depended on two factors -the blood urea and serum albumin levels. All other findings, including paraprotein type, paraprotein concentration, all radiological findings, and all histological findings, were of no statistically significant prognostic importance after adjustment for urea and albumin levels. The results of the trial showed that there was no significant difference in survival between the groups treated with cyclophosphamide and melphalan. The median survival for all 276 patients with myelomatosis admitted to the trial was eighteen months, and the estimated four-year survival was 20%. For those whose blood urea concentration at presentation was less than 40 mg/100 ml the median survival was thirty-three months, and the estimated fouryear survival was over 30 %. This goes some way to explain why this patient with increasing osteolytic lesions has survived thirteen years so far -her blood urea and serum albumin levels have remained in the normal range.
An interesting feature in this woman is the absence of a definite paraprotein band on recent serum electrophoresis and immunophoresis; Bence-Jones protein was not detected in the urine, although the urine may not have been sufficiently concentrated to detect a very small amount. In approximately 1 % of a group of patients with myelomatosis, no paraprotein could be detected in serum or urine concentrated 300 times (Hobbs 1969 Clinically his wrists, especially the left, showed limitation of range but other joints were normal.
In 1964 he began to have angina. One daughter has diabetes. Investigations: Hb 13.6 g/100 ml. ESR 17 mm in 1 hour (Westergren). Rose-Waaler and latex tests negative. Serum urate on three occasions 9.5, 9.5, 9.7 mg/100 ml. Serum cholesterol (fasting) 160, triglyceride (fasting) 140 mg/100 ml. Random blood sugar 55 mg/100 ml. Plasma calcium, phosphorus and alkaline phosphatase normal.
X-rays showed chondrocalcinosis, marked in the menisci and articular cartilages of both knees but slight in the wrist cartilage.
A biopsy of a nodule showed no evidence of urate crystals but histology was consistent with a necrobiotic nodule.
Comment
Necrobiotic nodules are seen in rheumatoid arthritis, Still's disease and rheumatic fever. Rheumatoid arthritis is unlikely here in view of the distribution and the negative serology. Solitary necrobiotic nodules have been described in patients with no organic disease. The histology of granuloma annulare is similar to that of a necrobiotic nodule. It is usually superficial and more common in children.
Clinically this case resembled subcutaneous granuloma annulare, but the histology was more like the necrobiosis seen in rheumatoid arthritis. The patient has features of pseudo-gout with chondrocalcinosis and hyperuricemia but has never had an episode of acute crystal synovitis. Necrobiotic nodules have not been described in pseudo-gout, so it appears that this is a chance association.
